Largest Chinese CRO, WuXi PharmaTech Co., Ltd., Purchases Multiyear ADMET Predictor License
11/12/2013 8:47:28 AM
LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus, Inc. (NASDAQ: SLP), a leading provider of consulting services and software for pharmaceutical discovery and development, today announced that WuXi PharmaTech (NYSE:WX), China’s largest contract research organization (CRO), has obtained a multiyear license to ADMET Predictor™, Simulations Plus’ flagship structure-to-property prediction software.
Help employers find you! Check out all the jobs and post your resume.
comments powered by